Revenue
2022
2023
2024
2025
Greenwich LifeSciences, Inc. (GLSI)
Price$15.78Cached quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — |
| Research & development | $17.2M | $15.5M | $7.7M | $6.5M | $3.6M | $1.1M | $2.6M |
| Operating expenses | $19.4M | $17.6M | $9.3M | $8.0M | $4.6M | $1.9M | $3.4M |
| Operating income | −$19.4M | −$17.6M | −$9.3M | −$8.0M | −$4.6M | −$1.9M | −$3.4M |
| EBITDA | −$19.4M | −$17.6M | −$9.3M | −$8.0M | — | — | — |
| Net income | −$19.4M | −$17.4M | −$8.9M | −$7.8M | −$4.6M | −$1.9M | −$3.4M |
| Basic EPSper basic share | -$1.43 | -$1.34 | -$0.69 | -$0.61 | -$0.35 | -$0.20 | -$1.52 |
| Diluted EPSper diluted share | -$1.43 | -$1.34 | -$0.69 | -$0.61 | -$0.35 | -$0.20 | -$1.52 |
Owners
Reported shareholders
≈38.18%of listed shares
Patel Snehal5.6M shares · Jan 13, 2026
View holders
| Holder | % owned |
|---|---|
Patel Snehal | ≈38.18%5.6M shares |
BlackRock, Inc. | 3.31%485.85K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 1.90%278.19K shares |
Thompson Jaye | ≈1.80%264.15K shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.15%168.18K shares |
STATE STREET CORP | 0.97%143.09K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.55%80.86K shares |
NORTHERN TRUST CORP | 0.55%80.23K shares |
Bank of New York Mellon Corp | 0.33%47.9K shares |
VANGUARD FIDUCIARY TRUST CO | 0.31%45.97K shares |
MORGAN STANLEY | 0.30%43.45K shares |
GOLDMAN SACHS GROUP INC | 0.27%39.33K shares |
Russell Investments Group, Ltd. | 0.23%34.35K shares |
JANE STREET GROUP, LLC | 0.19%27.69K shares |
UBS Group AG | 0.16%23.41K shares |
STATE OF WISCONSIN INVESTMENT BOARD | 0.15%22.64K shares |
GSA CAPITAL PARTNERS LLP | 0.13%19.54K shares |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.12%17.92K shares |
STRS OHIO | 0.12%17.8K shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.12%17.1K shares |
Percentages use 14.68M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 13, 2026Form 4 | Patel SnehalCEO and CFO | BuyCommon Stock | 1.8K | $29.83 | $53.7K | 5.60M |
| Jan 12, 2026Form 4 | Patel SnehalCEO and CFO | BuyCommon Stock | 2.9K | $27.54 | $79.9K | 5.60M |
| Dec 31, 2025Form 4 | Patel SnehalCEO and CFO | BuyCommon Stock | 4.3K | $21.36 | $91.8K | 5.60M |
| Dec 30, 2025Form 4 | Patel SnehalCEO and CFO | BuyCommon Stock | 2.9K | $21.73 | $63.0K | 5.60M |
| Dec 18, 2025Form 4 | Patel SnehalCEO and CFO | BuyCommon Stock | 4.1K | $12.62 | $51.7K | 5.59M |